ADVANCED LIFE SOLUTIONS – Trademark Portfolio

Entity Type: 99

ADVANCED LIFE SOLUTIONS holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include ALS ADVANCED LIFE SOLUTIONS.

121 route du Mulfier

F-01190 CHAVANNES-SUR-REYSSOUZE

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

ADVANCED LIFE SOLUTIONS's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does ADVANCED LIFE SOLUTIONS have?

ADVANCED LIFE SOLUTIONS has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered.

What trademark classes does ADVANCED LIFE SOLUTIONS file in?

ADVANCED LIFE SOLUTIONS files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are ADVANCED LIFE SOLUTIONS's most well-known trademarks?

ADVANCED LIFE SOLUTIONS's registered trademark portfolio includes well-known marks such as ALS ADVANCED LIFE SOLUTIONS. These are among 1 currently registered trademark in the portfolio.

What is ADVANCED LIFE SOLUTIONS's trademark registration success rate?

ADVANCED LIFE SOLUTIONS has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.